- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2867
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
A 6-gene signature identifies four molecular subgroups of neuroblastoma ; volume:11 ; number:1 ; day:14 ; month:4 ; year:2011 ; pages:1-15 ; date:12.2011
Cancer cell international ; 11, Heft 1 (14.4.2011), 1-15, 12.2011
- Urheber
-
Abel, Frida
- Beteiligte Personen und Organisationen
-
Dalevi, Daniel
Nethander, Maria
Jörnsten, Rebecka
De Preter, Katleen
Vermeulen, Joëlle
Stallings, Raymond
Kogner, Per
Maris, John
Nilsson, Staffan
SpringerLink (Online service)
- DOI
-
10.1186/1475-2867-11-9
- URN
-
urn:nbn:de:1111-2016073017436
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:03 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Abel, Frida
- Dalevi, Daniel
- Nethander, Maria
- Jörnsten, Rebecka
- De Preter, Katleen
- Vermeulen, Joëlle
- Stallings, Raymond
- Kogner, Per
- Maris, John
- Nilsson, Staffan
- SpringerLink (Online service)
Ähnliche Objekte (12)
Genome wide DNA methylation analysis identifies novel molecular subgroups and predicts survival in neuroblastoma
Autoantibody Signature Differentiates Wilms Tumor Patients from Neuroblastoma Patients
Gene expression signature of acquired chemoresistance in neuroblastoma cells
Proteomic characterization identifies clinically relevant subgroups of soft tissue sarcoma
Genomic analysis identifies frequent deletions of Dystrophin in olfactory neuroblastoma
Proteomic analysis identifies subgroups of patients with active systemic lupus erythematosus
Expression Profiling Identifies Circular RNA Signature in Hepatoblastoma
Development and validation of a 21-gene prognostic signature in neuroblastoma
Design of a multi-signature ensemble classifier predicting neuroblastoma patients' outcome
Genome-wide promoter methylation analysis in neuroblastoma identifies prognostic methylation biomarkers
DNA methylation profiling of central nervous system hemangioblastomas identifies two distinct subgroups
A molecular signature in blood identifies early Parkinson's disease
Genome wide DNA methylation analysis identifies novel molecular subgroups and predicts survival in neuroblastoma
Autoantibody Signature Differentiates Wilms Tumor Patients from Neuroblastoma Patients
Gene expression signature of acquired chemoresistance in neuroblastoma cells
Proteomic characterization identifies clinically relevant subgroups of soft tissue sarcoma
Genomic analysis identifies frequent deletions of Dystrophin in olfactory neuroblastoma
Proteomic analysis identifies subgroups of patients with active systemic lupus erythematosus
Expression Profiling Identifies Circular RNA Signature in Hepatoblastoma
Development and validation of a 21-gene prognostic signature in neuroblastoma
Design of a multi-signature ensemble classifier predicting neuroblastoma patients' outcome
Genome-wide promoter methylation analysis in neuroblastoma identifies prognostic methylation biomarkers
DNA methylation profiling of central nervous system hemangioblastomas identifies two distinct subgroups
A molecular signature in blood identifies early Parkinson's disease
Genome wide DNA methylation analysis identifies novel molecular subgroups and predicts survival in neuroblastoma
Autoantibody Signature Differentiates Wilms Tumor Patients from Neuroblastoma Patients
Gene expression signature of acquired chemoresistance in neuroblastoma cells
Proteomic characterization identifies clinically relevant subgroups of soft tissue sarcoma
Genomic analysis identifies frequent deletions of Dystrophin in olfactory neuroblastoma
Proteomic analysis identifies subgroups of patients with active systemic lupus erythematosus
Expression Profiling Identifies Circular RNA Signature in Hepatoblastoma
Development and validation of a 21-gene prognostic signature in neuroblastoma
Design of a multi-signature ensemble classifier predicting neuroblastoma patients' outcome
Genome-wide promoter methylation analysis in neuroblastoma identifies prognostic methylation biomarkers
DNA methylation profiling of central nervous system hemangioblastomas identifies two distinct subgroups